Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03279523 · ClinicalTrials.gov registry record
F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected
A clinical trial, sponsored by Tammie L. S. Benzinger, MD, PhD.
- Completed
- Registry status
- 60
- Enrollment target
NCT03279523 is a clinical trial that has completed, run by Tammie L. S. Benzinger, MD, PhD. The registered enrollment target is 60 participants.
The verdict
NCT03279523 has completed, sponsored by Tammie L. S. Benzinger, MD, PhD.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This project will collect quantitative pilot data that will allow the characterization of uptake and binding of 18F-AV-1451 (also known as F 18 T807, also known as T807, also known as 7-(6-fluoropyridin-3-yl)-5H-pyrido\[4,3-b\]indole), a novel tau imaging compound, in older HIV+ individuals with and without HAND and matched HIV uninfected (HIV-) controls. The primary goal is to develop this highly promising tau imaging technique as an biomarker of cognitive decline in HIV+ individuals. The investigators will obtain preliminary data that will support the possibility of detecting early brain pathological changes due to HIV. Data generated from this study will be used for submission of National Institutes of Health (NIH) grants comparing tau deposition in HAND compared to other neurodegenerative disorders. It is hypothesized that specific topographies will help distinguish these neurodegenerative disorders in older individuals.
Interventions
- DRUG F 18 T807
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-05-03 |
| Est. Completion | 2018-05-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03279523
The ClinicalTrials.gov registry entry for NCT03279523 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tammie L. S. Benzinger, MD, PhD, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which F 18 T807 is the first listed.
NCT03279523 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03279523 about?
NCT03279523 is a clinical study titled "F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected". This project will collect quantitative pilot data that will allow the characterization of uptake and binding of 18F-AV-1451 (also known as F 18 T807, also known as T807, also known as 7-(6-fluoropyridin-3-yl)-5H-pyrido\[4,3-b\]indole), a novel tau imaging compound, in older HIV+ individuals with and...
What is the current status of trial NCT03279523?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2016-05-03. Estimated completion is 2018-05-23.
What interventions are being tested in trial NCT03279523?
The interventions under investigation include: F 18 T807 (DRUG).
Who is sponsoring clinical trial NCT03279523?
This trial is sponsored by Tammie L. S. Benzinger, MD, PhD, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.